Cargando…
Treatment of Keratoacanthoma with 5% Imiquimod Cream and Review of the Previous Report
Keratoacanthoma (KA) is a benign epidermal tumor, characterized by rapid and abundant growth, a tendency toward spontaneous regression and histopathologic similarity to squamous cell carcinoma (SCC). Because KA can be easily misdiagnosed as SCC, surgery is considered the treatment of choice. Recentl...
Autores principales: | Jeon, Hye Chan, Choi, Mira, Paik, Seung Hwan, Ahn, Chang Ho, Park, Hyun Sun, Cho, Kwang Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Dermatological Association; The Korean Society for Investigative Dermatology
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162267/ https://www.ncbi.nlm.nih.gov/pubmed/21909208 http://dx.doi.org/10.5021/ad.2011.23.3.357 |
Ejemplares similares
-
Successful treatment of a keratoacanthoma in a young patient with the application of topical 5% imiquimod cream
por: Plachouri, Kerasia‐Maria, et al.
Publicado: (2021) -
Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma
por: Pancevski, Goran, et al.
Publicado: (2018) -
Cryosurgery, Intralesional Methotrexate and Imiquimod for Keratoacanthoma: Tuning the Combination
por: Gaitanis, Georgios, et al.
Publicado: (2019) -
Imiquimod (Aldara cream).
por: Buck, H W
Publicado: (1998) -
Efficacy of 5% Imiquimod Cream on Vulvar Intraepithelial Neoplasia in Korea: Pilot Study
por: Kim, Jeong-Min, et al.
Publicado: (2015)